Marie-Annick Buendia

Title: Marie-Annick Buendia: Innovator in Liver Tumor Prognosis

Introduction

Marie-Annick Buendia is a prominent inventor based in Le Perreux sur Marne, France. She has made significant contributions to the field of medical research, particularly in the area of liver tumors. Her innovative work has led to the development of a method that aids in the evaluation of liver tumor grades and therapeutic regimens.

Latest Patents

Marie-Annick Buendia holds a patent titled "Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen." This invention concerns a method to determine the gene expression profile on a sample obtained from a patient diagnosed with a liver tumor. The method involves assaying the expression of a set of genes in the sample and determining the gene expression profile, which can help identify the grade of the liver tumor, such as hepatoblastoma (HB) or hepatocellular carcinoma (HCC). Additionally, the invention includes kits comprising pairs of primers or probes specific for a set of genes, which are useful for determining the tumor grade and assessing the risk of metastasis.

Career Highlights

Throughout her career, Marie-Annick Buendia has worked with esteemed institutions such as the National Institute of Health and Medical Research and Institut Pasteur. Her research has significantly advanced the understanding of liver tumors and their treatment options.

Collaborations

Marie-Annick has collaborated with notable colleagues, including Stefano Cairo and Aurélien De Reynies, contributing to the advancement of research in her field.

Conclusion

Marie-Annick Buendia's innovative work in the field of liver tumor research exemplifies her dedication to improving patient outcomes through scientific advancements. Her contributions continue to influence the medical community and pave the way for future innovations.